Telomerase reverse transcriptase promoter mutation- and O6-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?

被引：12

作者：

Gramatzki, Dorothee ^{[1
,2
]}

Felsberg, Joerg ^{[3
]}

Hentschel, Bettina ^{[4
]}

Wolter, Marietta ^{[3
]}

Schackert, Gabriele ^{[5
]}

Westphal, Manfred ^{[6
]}

Regli, Luca ^{[2
,7
]}

Thon, Niklas ^{[8
]}

Tatagiba, Marcos ^{[9
]}

Wick, Wolfgang ^{[10
,11
]}

Schlegel, Uwe ^{[12
]}

Krex, Dietmar ^{[5
]}

Matschke, Jakob ^{[13
]}

Roth, Patrick ^{[1
,2
]}

Suresh, Marian P. ^{[14
]}

Kamp, Marcel A. ^{[14
]}

Rushing, Elisabeth J. ^{[2
,15
]}

Pietsch, Torsten ^{[16
]}

von Deimling, Andreas ^{[17
,18
,19
]}

Sabel, Michael ^{[14
]}

Loeffler, Markus ^{[4
]}

Weller, Michael ^{[1
,2
]}

Reifenberger, Guido ^{[3
,20
]}

机构：

[1] Univ Hosp, Dept Neurol, Zurich, Switzerland

[2] Univ Zurich, Zurich, Switzerland

[3] Heinrich Heine Univ, Med Fac, Inst Neuropathol, Dusseldorf, Germany

[4] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany

[5] Univ Dresden, Dept Neurosurg, Dresden, Germany

[6] Univ Hamburg, Dept Neurosurg, Hamburg, Germany

[7] Univ Hosp, Dept Neurosurg, Zurich, Switzerland

[8] Ludwig Maximilians Univ Munchen, Dept Neurosurg, Munich, Germany

[9] Univ Tubingen, Interdisciplinary Div Neurooncol, Dept Neurosurg, Tubingen, Germany

[10] Univ Hosp Heidelberg, Dept Neurol, Heidelberg, Germany

[11] German Canc Res Ctr, German Canc Consortium DKTK, Clin Cooperat Unit Neurooncol, Heidelberg, Germany

[12] Ruhr Univ Bochum, Univ Hosp Knappschaftskrankenhaus, Dept Neurol, Bochum, Germany

[13] Univ Hamburg, Inst Neuropathol, Hamburg, Germany

[14] Heinrich Heine Univ, Med Fac, Dept Neurosurg, Dusseldorf, Germany

[15] Univ Hosp, Dept Neuropathol, Zurich, Switzerland

[16] Univ Hosp Bonn, DGNN Brain Tumor Reference Ctr, Dept Neuropathol, Bonn, Germany

[17] Univ Hosp Heidelberg, Dept Neuropathol, Heidelberg, Germany

[18] German Canc Ctr DKFZ, CCU Neuropathol, Heidelberg, Germany

[19] German Canc Ctr DKFZ, DKTK, Heidelberg, Germany

[20] German Canc Res Ctr, German Canc Consortium, Partner Site Essen Dusseldorf, Heidelberg, Germany

来源：

EUROPEAN JOURNAL OF CANCER | 2021年 / 147卷

关键词：

Glioblastoma; IDH-; wild-type; MGMT; TERT; Temozolomide; Survival; GLIOMAS; MGMT; TUMORS; CLASSIFICATION; RADIOTHERAPY; COMBINATION; DIAGNOSIS; GENES; OCCUR;

D O I：

10.1016/j.ejca.2021.01.014

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Aim of the study: Benefit from temozolomide (TMZ) chemotherapy in the treatment of isocitrate dehydrogenase (IDH)-wild-type glioblastoma is essentially limited to patients with O-6-methylguanine DNA methyltransferase (MGMT) promoter-methylated tumours. Recent studies suggested that telomerase reverse transcriptase (TERT) promoter hotspot mutations may have an impact on the prognostic role of the MGMT status in patients with glioblastoma. Methods: MGMT promoter methylation and TERT promoter mutation status were retrospectively assessed in a prospective cohort of patients with IDH-wild-type glioblastoma of the German Glioma Network (GGN) (n = 298) and an independent retrospective cohort from Dusseldorf, Germany, and Zurich, Switzerland (n = 302). Results: In the GGN cohort, but not in the Dusseldorf/Zurich cohort, TERT promoter mutation was moderately associated with inferior outcomes in patients with MGMT promoter-unmethylated tumours (hazard ratio 1.74; 95% confidence interval: 1.07-2.82; p = 0.026). TERT promoter mutations were not associated with better outcomes in patients with MGMT promoter-methylated tumours in either cohort. The two different TERT promoter hotspot mutations (C228T and C250T) were not linked to distinct outcomes. Conclusions: Analysis of two independent cohorts of patients with glioblastoma did not confirm previous data, suggesting that TERT promoter mutations confer an enhanced benefit from TMZ in patients with MGMT promoter-methylated glioblastoma. Thus, diagnostic testing for TERT promoter mutations may not be required for prediction of TMZ sensitivity in patients with IDH-wild-type glioblastoma. (C) 2021 The Authors. Published by Elsevier Ltd.

引用

页码：84 / 94

页数：11

共 41 条

[1] TERT promoter mutation subtypes and survival in stage I and II melanoma patients [J].

Andres-Lencina, Juan J. ;

Rachakonda, Sivaramakrishna ;

Garcia-Casado, Zaida ;

Srinivas, Nalini ;

Skorokhod, Alexander ;

Requena, Celia ;

Soriano, Virtudes ;

Kumar, Rajiv ;

Nagore, Eduardo .

INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (05) :1027-1036

[2] A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas [J].

Arita, Hideyuki ;

Yamasaki, Kai ;

Matsushita, Yuko ;

Nakamura, Taishi ;

Shimokawa, Asanao ;

Takami, Hirokazu ;

Tanaka, Shota ;

Mukasa, Akitake ;

Shirahata, Mitsuaki ;

Shimizu, Saki ;

Suzuki, Kaori ;

Saito, Kuniaki ;

Kobayashi, Keiichi ;

Higuchi, Fumi ;

Uzuka, Takeo ;

Otani, Ryohei ;

Tamura, Kaoru ;

Sumita, Kazutaka ;

Ohno, Makoto ;

Miyakita, Yasuji ;

Kagawa, Naoki ;

Hashimoto, Naoya ;

Hatae, Ryusuke ;

Yoshimoto, Koji ;

Shinojima, Naoki ;

Nakamura, Hideo ;

Kanemura, Yonehiro ;

Okita, Yoshiko ;

Kinoshita, Manabu ;

Ishibashi, Kenichi ;

Shofuda, Tomoko ;

Kodama, Yoshinori ;

Mori, Kanji ;

Tomogane, Yusuke ;

Fukai, Junya ;

Fujita, Koji ;

Terakawa, Yuzo ;

Tsuyuguchi, Naohiro ;

Moriuchi, Shusuke ;

Nonaka, Masahiro ;

Suzuki, Hiroyoshi ;

Shibuya, Makoto ;

Maehara, Taketoshi ;

Saito, Nobuhito ;

Nagane, Motoo ;

Kawahara, Nobutaka ;

Ueki, Keisuke ;

Yoshimine, Toshiki ;

Miyaoka, Etsuo ;

Nishikawa, Ryo .

ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2016, 4 :79

[3] Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss [J].

Arita, Hideyuki ;

Narita, Yoshitaka ;

Fukushima, Shintaro ;

Tateishi, Kensuke ;

Matsushita, Yuko ;

Yoshida, Akihiko ;

Miyakita, Yasuji ;

Ohno, Makoto ;

Collins, V. Peter ;

Kawahara, Nobutaka ;

Shibui, Soichiro ;

Ichimura, Koichi .

ACTA NEUROPATHOLOGICA, 2013, 126 (02) :267-276

[4] Systematic analysis of telomere length and somatic alterations in 31 cancer types [J].

Barthel, Floris P. ;

Wei, Wei ;

Tang, Ming ;

Martinez-Ledesma, Emmanuel ;

Hu, Xin ;

Amin, Samirkumar B. ;

Akdemir, Kadir C. ;

Seth, Sahil ;

Song, Xingzhi ;

Wang, Qianghu ;

Lichtenberg, Tara ;

Hu, Jian ;

Zhang, Jianhua ;

Zheng, Siyuan ;

Verhaak, Roel G. W. .

NATURE GENETICS, 2017, 49 (03) :349-357

[5] cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV" [J].

Brat, Daniel J. ;

Aldape, Kenneth ;

Colman, Howard ;

Holland, Eric C. ;

Louis, David N. ;

Jenkins, Robert B. ;

Kleinschmidt-DeMasters, B. K. ;

Perry, Arie ;

Reifenberger, Guido ;

Stupp, Roger ;

von Deimling, Andreas ;

Weller, Michael .

ACTA NEUROPATHOLOGICA, 2018, 136 (05) :805-810

[6] Monoclonal antibody specific for IDH1 R132H mutation [J].

Capper, David ;

Zentgraf, Hanswalter ;

Balss, Joerg ;

Hartmann, Christian ;

von Deimling, Andreas .

ACTA NEUROPATHOLOGICA, 2009, 118 (05) :599-601

[7] Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma [J].

Ceccarelli, Michele ;

Barthel, Floris P. ;

Malta, Tathiane M. ;

Sabedot, Thais S. ;

Salama, Sofie R. ;

Murray, Bradley A. ;

Morozova, Olena ;

Newton, Yulia ;

Radenbaugh, Amie ;

Pagnotta, Stefano M. ;

Anjum, Samreen ;

Wang, Jiguang ;

Manyam, Ganiraju ;

Zoppoli, Pietro ;

Ling, Shiyun ;

Rao, Arjun A. ;

Grifford, Mia ;

Cherniack, Andrew D. ;

Zhang, Hailei ;

Poisson, Laila ;

Carlotti, Carlos Gilberto, Jr. ;

Tirapelli, Daniela Pretti da Cunha ;

Rao, Arvind ;

Mikkelsen, Tom ;

Lau, Ching C. ;

Yung, W. K. Alfred ;

Rabadan, Raul ;

Huse, Jason ;

Brat, Daniel J. ;

Lehman, Norman L. ;

Barnholtz-Sloan, Jill S. ;

Zheng, Siyuan ;

Hess, Kenneth ;

Rao, Ganesh ;

Meyerson, Matthew ;

Beroukhim, Rameen ;

Cooper, Lee ;

Akbani, Rehan ;

Wrensch, Margaret ;

Haussler, David ;

Aldape, Kenneth D. ;

Laird, Peter W. ;

Gutmann, David H. ;

Noushmehr, Houtan ;

Iavarone, Antonio ;

Verhaak, Roel G. W. .

CELL, 2016, 164 (03) :550-563

[8] Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples [J].

Corless, Broderick C. ;

Chang, Gregory A. ;

Cooper, Samantha ;

Syeda, Mahrukh M. ;

Shao, Yongzhao ;

Osman, Iman ;

Karlin-Neumann, George ;

Polsky, David .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (02) :274-285

[9] The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma [J].

Diplas, Bill H. ;

He, Xujun ;

Brosnan-Cashman, Jacqueline A. ;

Liu, Heng ;

Chen, Lee H. ;

Wang, Zhaohui ;

Moure, Casey J. ;

Killela, Patrick J. ;

Loriaux, Daniel B. ;

Lipp, Eric S. ;

Greer, Paula K. ;

Yang, Rui ;

Rizzo, Anthony J. ;

Rodriguez, Fausto J. ;

Friedman, Allan H. ;

Friedman, Henry S. ;

Wang, Sizhen ;

He, Yiping ;

McLendon, Roger E. ;

Bigner, Darell D. ;

Jiao, Yuchen ;

Waitkus, Matthew S. ;

Meeker, Alan K. ;

Yan, Hai .

NATURE COMMUNICATIONS, 2018, 9

[10] Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors [J].

Eckel-Passow, Jeanette E. ;

Lachance, Daniel H. ;

Molinaro, Annette M. ;

Walsh, Kyle M. ;

Decker, Paul A. ;

Sicotte, Hugues ;

Pekmezci, Melike ;

Rice, Terri ;

Kosel, Matt L. ;

Smirnov, Ivan V. ;

Sarkar, Gobinda ;

Caron, Alissa A. ;

Kollmeyer, Thomas M. ;

Praska, Corinne E. ;

Chada, Anisha R. ;

Halder, Chandralekha ;

Hansen, Helen M. ;

Mccoy, Lucie S. ;

Bracci, Paige M. ;

Marshall, Roxanne ;

Zheng, Shichun ;

Reis, Gerald F. ;

Pico, Alexander R. ;

O'Neill, Brian P. ;

Buckner, Jan C. ;

Giannini, Caterina ;

Huse, Jason T. ;

Perry, Arie ;

Tihan, Tarik ;

Berger, Mitchell S. ;

Chang, Susan M. ;

Prados, Michael D. ;

Wiemels, Joseph ;

Wiencke, John K. ;

Wrensch, Margaret R. ;

Jenkins, Robert B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26) :2499-2508

← 1 2 3 4 5 →